D. Schwab

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D Schwab, D. Schwab, Dietmar Schwab
Publication record
27 papers · 1,080 citations · H-index 13

PAPERS

Enabling Subcutaneous Dosing of Gantenerumab in Alzheimer’s Disease (S14.006)
20230 citationsauthor #2
A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
20218 citationsauthor #2
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
2020102 citationsauthor #9
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
2019236 citationsauthor #11
Ocular half-life of intravitreal biologics in humans and other species: meta-analysis and model-based prediction.
201950 citationsauthor #7
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus
201811 citationsauthor #3
Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study
201711 citationsauthor #1
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration.
201777 citationsauthor #17
Chapter 10:Transporter Drug–Drug Interactions: A Pharmaceutical Industry Perspective
20160 citationsauthor #4
What is the biologically relevant KD for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates.
20163 citationsauthor #2
A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.
201678 citationsauthor #5
AM AAV 2 Mediated Expression of Intraceptor Flt 23 k Shows No Endoplasmic Reticulum Stress Response
20160 citationsauthor #10
The novel bispecific monoclonal anti-VEGF/anti-Ang2 antibody RG7716 shows promise in wet age-related macular degeneration patients with suboptimal response to prior anti-VEGF monotherapy
20162 citationsauthor #2
Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)
201680 citationsauthor #2
Metabolism and mass balance of SGLT2 inhibitor tofogliflozin following oral administration to humans
201421 citationsauthor #4
A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans
201340 citationsauthor #1
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
200737 citationsauthor #9
Clinical and in‐vitro investigations to assess transporter based drug interaction potential of a partial alpha agonist R450
20050 citationsauthor #2
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
2003201 citationsauthor #1
Uptake of 3 a , 7 a , 1 2 a-trihydroxy-24-nor-5 g-cholan-23-sulfonate into isolated rat hepatocytes by three transport systems
20020 citationsauthor #1
Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR(-)) by the glucose-6-phosphate translocase inhibitor S 3025.
200216 citationsauthor #2
Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system.
199876 citationsauthor #3
Uptake of 3 alpha, 7 alpha, 12 alpha-trihydroxy-24-nor-5 beta-cholan-23-sulfonate into isolated rat hepatocytes by three transport systems.
19975 citationsauthor #1
Uptake of 3α,7α, 12α-trihydroxy-24-nor-5β-cholan- 23-sulfonate into isolated rat hepatocytes by three transport systems
19972 citationsauthor #1
3a, 7a, 1 2a-Tri hyd roxy=24-nor-5~-cholan-23-s~ lfonate: synthesis and suitability for the study of cholate transport'
19960 citationsauthor #1
3 alpha, 7 alpha, 12 alpha-trihydroxy-24-nor-5 beta-cholan-23-sulfonate: synthesis and suitability for the study of cholate transport.
19962 citationsauthor #1
Heterogeneity in hepatic transport of somatostatin analog octapeptides
199425 citationsauthor #3

TIMELINE

1994 25 citations

1996 2 citations

1997 7 citations

1998 76 citations

2002 16 citations

2003 201 citations

2005 0 citations

2007 37 citations

2013 40 citations

2014 21 citations

2016 163 citations

2017 88 citations

2018 11 citations

2019 286 citations

2020 102 citations

2021 8 citations

2023 0 citations

D. Schwab

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT